General Oncology

Immune Response After Breakthrough Infection or Fourth COVID-19 Vaccine Dose in Cancer Patients

By

Jessica Nye, PhD

Publish Date March 24, 2023

Researchers sought to determine the humoral immune response to the COVID-19 vaccine in patients with cancer after a third or fourth dose of the vaccine or breakthrough infection.

Discrimination Linked to Frailty in African American Cancer Survivors

Publish Date March 24, 2023

Survivors with four to seven types of discrimination events had large, clinically meaningful increase in deficits.

Nirogacestat Gets Priority Review for Treatment of Desmoid Tumors

By

Brian Park, PharmD

Publish Date March 22, 2023

Nirogacestat is an oral, selective, small molecule gamma-secretase inhibitor that works by blocking proteolytic activation of Notch receptors.

Novel Treatment Approach May Reduce Risk of Death From ICI-Related Myocarditis

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date March 16, 2023

A novel method of treating immune checkpoint inhibitor-associated myocarditis may decrease the risk of death from myotoxicity.

Artificial Intelligence Can Predict Cancer Survival Using Data From a Single Consultation

By

Laura Healy

Publish Date March 14, 2023

Artificial intelligence can predict survival in cancer patients using information from a patient’s initial consultation with an oncologist, a study suggests.